CLINICAL THYROIDOLOGY FOR THE PUBLIC
A publication of the American Thyroid Association
Welcome to another issue of Clinical Thyroidology for the Public. In this journal, we will bring to you the most up-to-date, cutting edge thyroid research. We will be providing summaries of research studies that were discussed in a recent issue of Clinical Thyroidology, a publication of the American Thyroid Association for physicians. These summaries are present in lay language to allow the rapid dissemination of thyroid research to the widest possible audience. This means that you are getting the latest information on thyroid research and treatment almost as soon as your physicians. As always, we are happy to entertain any suggestions to improve Clinical Thyroidology for the Public so let us know what you want to see.
We also provide even faster updates of late-breaking thyroid news through Twitter at @thyroidfriends and on Facebook. Our goal is to provide patients with the tools to be the most informed thyroid patient in the waiting room.
Also check out our friends in the Alliance for Thyroid Patient Education. The Alliance member groups consist of: the American Thyroid Association, Bite Me Cancer, the Graves’ Disease and Thyroid Foundation, the Light of Life Foundation, ThyCa: Thyroid Cancer Survivors Association, Thyroid Cancer Canada and Thyroid Federation International.
December is Thyroid and Development Month.
In this issue, the studies ask the following questions:
- Is estrogen the reason why thyroid cancer is more common in women?
- Is thyroid disease associated with increased mortality in the elderly?
- Is thyroid disease more common in patient on dialysis?
- What is the best way to manage abnormal neck nodes after surgery in patients with thyroid cancer?
- Is the incidence of thyroid cancer actually increasing?
- Is Sorafanib effective in patients with medullary thyroid cancer?
We welcome your feedback and suggestions. Let us know what you want to see in this publication. I hope you find these summaries interesting and informative.
— Alan P. Farwell, MD, FACE